Certified Nephrology Nurse Certification (CNN) Practice Exam 2026 - Free Nephrology Nursing Practice Questions and Study Guide

In the context of chronic kidney disease (CKD), osteodystrophy is a significant complication that directly impacts bone health. This condition, often referred to as renal osteodystrophy, arises due to the disrupted balance of calcium, phosphorus, vitamin D, and parathyroid hormone in patients with kidney dysfunction.

As renal function declines, the kidneys are less able to excrete phosphate, leading to hyperphosphatemia. This condition stimulates the secretion of parathyroid hormone (PTH), which increases calcium release from bones, thus contributing to bone weakening. Additionally, decreased production of activated vitamin D by the kidneys impairs intestinal absorption of calcium, further complicating the bone health of these patients.

Overall, renal osteodystrophy manifests as a combination of changes in bone mineral density, abnormal bone formation, and altered bone structure, leading to increased fragility and a higher risk of fractures. Therefore, this makes osteodystrophy a crucial complication to monitor and manage in patients with chronic kidney disease for optimal skeletal health.